Post-approval studies (Phase 4)Study completedNCT00442325
What this trial is testing
Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets
Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 595